Compare SXTC & BBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXTC | BBU |
|---|---|---|
| Founded | 2005 | 2016 |
| Country | China | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.7M | 2.8B |
| IPO Year | 2019 | N/A |
| Metric | SXTC | BBU |
|---|---|---|
| Price | $1.93 | $34.54 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $34.67 |
| AVG Volume (30 Days) | ★ 105.8K | 19.6K |
| Earning Date | 08-19-2019 | 01-30-2026 |
| Dividend Yield | N/A | ★ 0.68% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,537,987.00 | ★ $27,790,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.95 | $18.63 |
| 52 Week High | $7.84 | $37.38 |
| Indicator | SXTC | BBU |
|---|---|---|
| Relative Strength Index (RSI) | 71.55 | 42.70 |
| Support Level | $1.61 | $35.14 |
| Resistance Level | $1.61 | $37.38 |
| Average True Range (ATR) | 0.12 | 1.14 |
| MACD | 0.04 | -0.16 |
| Stochastic Oscillator | 98.18 | 3.58 |
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
Brookfield Business Partners LP is a business services and industrials company. It focused on operating businesses that are either low-cost producers and benefit from high barriers to entry. The company's operating segment includes Business services; Infrastructure services; Industrials and Corporate and other. It generates maximum revenue from the Business Services segment. Geographically operates in USA, Europe, Australia, Brazil, Canada, UK, Mexico and Other, majority of revenue is from UK.